Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4036265 | 0.94 | BRAF (0.42) | BRAFMAPK14 | |
| SCHEMBL4032953 | 0.94 | BRAF (0.43) | BRAFMAPK14 | |
| SCHEMBL303466 | 0.93 | BRAF (0.39) | BRAFMAPK14 | |
| SCHEMBL4031171 | 0.93 | BRAF (0.46) | BRAFMAPK14 | |
| SCHEMBL4033327 | 0.91 | BRAF (0.45) | BRAFMAPK14 | |
| SCHEMBL5057439 | 0.91 | BRAF (0.40) | BRAFMAPK14 | |
| SCHEMBL301852 | 0.89 | BRAF (0.49) | BRAFMAPK14 | |
| SCHEMBL4034135 | 0.89 | BRAF (0.43) | BRAFMAPK14 | |
| SCHEMBL4031982 | 0.89 | BRAF (0.43) | BRAFMAPK14 | |
| SCHEMBL4034101 | 0.88 | BRAF (0.45) | BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1725544-B1 | 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMA (US) | 2009-05-27 | — | — | EP | claimed |
| EP-1725544-A1 | 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005090333-A1 | 3-‘4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |